University Hospitals Divest from Medical Supply Intermediaries Amid Stricter Regulations

[Fact Check]

New amendments to the Medical Device Act, effective late 2027, restrict transactions between hospitals and affiliated supply intermediaries (known as 'gannapsa'). Consequently, major university hospitals like Asan Medical Center and Eulji University Hospital are divesting their stakes in these firms. This shift is expected to dismantle traditional exclusive supply chains and force a transformation in hospital procurement and logistics.

[AIxLogis Insight]

As you navigate this transition, keep in mind that this is more than just a regulatory compliance check; it is a fundamental shift in hospital logistics. For years, these intermediaries operated within closed, exclusive supply chains. Now, hospitals are being forced to adopt more transparent, competitive procurement processes. If you are working with these suppliers, you will notice that their value is no longer just about 'who they know,' but about their actual logistics efficiency and cost-competitiveness.

From a logistics standpoint, the key takeaway is the need for supply chain diversification. As these intermediaries change ownership, the stability of your existing supply lines might be at risk. You should be looking at how to maintain service levels during this transition. It is the perfect time to push for more data-driven inventory management and to evaluate whether your current partners can actually handle the complexities of modern medical supply chain requirements.

[Action Plan]

1. Audit your current supply chain: Check the ownership structure of your intermediaries and identify any potential contract renewal risks.
2. Diversify your procurement: If you rely heavily on a single intermediary, start vetting alternative suppliers to mitigate potential disruptions.
3. Digitalize your procurement: Invest in WMS or digital tracking tools to ensure full transparency and efficiency in your medical supply operations.

---

Original source: 네이버뉴스